ADST Technologies

About

ADST Technologies has developed an automated, safe, completely sterile, user-friendly, time-saving device for mass vaccination. ADSTs product is a disposable syringe device designed specifically to prevent the spread of disease. The needles are sterile until the moment of the injection, after which the device automatically replaces the needle, eliminating the possibility of reuse. The device also possesses an internal disinfection mode and meets the IP65 rating for external sterilization. ADST Technologies is a subsidiary of Goldman Hirsh Partners.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary product developed by ADST Technologies?

ADST Technologies developed an automated, safe, completely sterile, user-friendly, and time-saving device for mass vaccination. The product is a disposable syringe device designed to prevent disease spread by automatically replacing the needle after each injection and possessing an internal disinfection mode.

When was ADST Technologies founded?

ADST Technologies was founded in September 2013.

What is the current operational status of ADST Technologies?

ADST Technologies is currently inactive, having ceased operations in May 2022.

Where is ADST Technologies headquartered?

ADST Technologies is headquartered in Herzliya, Israel, at Abba Eban Ave 1.

How many employees did ADST Technologies have?

ADST Technologies had 6 employees.

Who is a founder of ADST Technologies?

Shaul Wolfstein is a founder of ADST Technologies.

What is ADST Technologies' relationship with Goldman Hirsh Partners?

ADST Technologies is a subsidiary of Goldman Hirsh Partners.

In which sector does ADST Technologies primarily operate?

ADST Technologies primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Target customers

Healthcare & Life SciencesHealthcareProvidersPatientsAgriculture & FoodLivestock

Business model

B2B

ADST Technologies — Full Company Profile (machine-readable)

Mass Injection Devices

About

Facts

Name	ADST Technologies
Slug	adst-technologies
Type	Israeli Startup
Founded	2013
HQ city	Herzliya
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object], [object Object], [object Object], [object Object]
Status	inactive
Current stage	Mature
Public stage	Mature
Total raised (USD)	0
Website	http://www.adst.co.il/
Crunchbase ID	adst-technologies
Israeli Companies Registrar	513455972

Team (3)

Name	Role	LinkedIn
Avi Yohanan
Shaul Wolfstein
Dr. Gil Pogozelich

Intelligence Q&A

What is the primary product developed by ADST Technologies?

When was ADST Technologies founded?

ADST Technologies was founded in September 2013.

What is the current operational status of ADST Technologies?

ADST Technologies is currently inactive, having ceased operations in May 2022.

Where is ADST Technologies headquartered?

ADST Technologies is headquartered in Herzliya, Israel, at Abba Eban Ave 1.

How many employees did ADST Technologies have?

ADST Technologies had 6 employees.

Who is a founder of ADST Technologies?

Shaul Wolfstein is a founder of ADST Technologies.

What is ADST Technologies' relationship with Goldman Hirsh Partners?

ADST Technologies is a subsidiary of Goldman Hirsh Partners.

In which sector does ADST Technologies primarily operate?

ADST Technologies primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

About

Company Intelligence Q&A

Sectors & technology

Highlights

Tags